These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27659822)

  • 1. An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.
    Lassaletta A; Zapotocky M; Bouffet E; Hawkins C; Tabori U
    Childs Nerv Syst; 2016 Oct; 32(10):1789-97. PubMed ID: 27659822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
    Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
    Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
    Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.
    Bergthold G; Bandopadhayay P; Hoshida Y; Ramkissoon S; Ramkissoon L; Rich B; Maire CL; Paolella BR; Schumacher SE; Tabak B; Ferrer-Luna R; Ozek M; Sav A; Santagata S; Wen PY; Goumnerova LC; Ligon AH; Stiles C; Segal R; Golub T; Grill J; Ligon KL; Chan JA; Kieran MW; Beroukhim R
    Neuro Oncol; 2015 Nov; 17(11):1486-96. PubMed ID: 25825052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.
    Lin A; Rodriguez FJ; Karajannis MA; Williams SC; Legault G; Zagzag D; Burger PC; Allen JC; Eberhart CG; Bar EE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):66-72. PubMed ID: 22157620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.
    Wagner MW; Nobre L; Namdar K; Khalvati F; Tabori U; Hawkins C; Ertl-Wagner BB
    AJNR Am J Neuroradiol; 2023 Jul; 44(7):841-845. PubMed ID: 37348970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
    Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
    Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
    Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric low-grade gliomas can be molecularly stratified for risk.
    Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
    Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.
    Trisolini E; Wardighi DE; Giry M; Bernardi P; Boldorini RL; Mokhtari K; Sanson M
    J Neurooncol; 2019 Nov; 145(2):241-245. PubMed ID: 31673897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric low-grade glioma in the era of molecular diagnostics.
    Ryall S; Tabori U; Hawkins C
    Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
    Tateishi K; Nakamura T; Yamamoto T
    Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
    Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
    Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
    [No Abstract]   [Full Text] [Related]  

  • 15. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
    Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
    J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
    Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
    Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.
    Suzuki Y; Takahashi-Fujigasaki J; Akasaki Y; Matsushima S; Mori R; Karagiozov K; Joki T; Ikeuchi S; Ikegami M; Manome Y; Murayama Y
    Brain Tumor Pathol; 2016 Jan; 33(1):40-9. PubMed ID: 26445861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
    Raabe E; Kieran MW; Cohen KJ
    Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.